From left, Ye Jae-chun, Office Director of the Korea Pharmaceutical Research Association, Kim Deok-sang, Vice Chairman of the Advanced Regenerative Medical Industry Association, Lee Seung-kyu, Vice Chairman of the Korea Bio Industry Association, Ryu Hyung-seon, Chairman of the Korea Pharmaceutical Export-Import Association, Hong Sung-han, Director of the Korea Pharmaceutical Research Association, Noh Yeon-hong, Chairman of the Korea Pharmaceutical Bio Association, Kim Young-min, Chairman of the Korea Medical Device Industry Association, Park Jung-tae, Vice Chairman of the Korea Bio Pharmaceutical Association, Kim Young-woong, Vice Chairman of the Korea Digital Health Industry Association, Lee Dong-hee, Vice Chairman of the Korea Pharmaceutical Export-Import Association, Kim Myung-jeong, Vice Chairman of the Korea Medical Device Industry Association, and Lee Jae-guk, Vice Chairman of the Korea Pharmaceutical Bio Association. Provided by the Korea Pharmaceutical Bio Association., “The Korea Pharmaceutical Bio Healthcare Alliance held a breakfast meeting in Dalgaebee, Jung-gu, Seoul on the 16th to focus on consolidating the sustainable ecosystem of the Korean pharmaceutical and bio healthcare industry.”,
,
, ‘The meeting was attended by around 20 people, including the heads of 8 organizations such as the Korea Pharmaceutical Bio Association, Korea Bio Pharmaceutical Association, Korea Pharmaceutical Export-Import Association, Advanced Regenerative Medical Industry Association, Korea Pharmaceutical Research Association, Korea Bio Industry Association, Korea Medical Device Industry Association, and Korea Digital Health Industry Association.’,
,
, ‘Yeon-hong Noh, the chairman of the alliance, said, “In order to lead the sustainable growth of our industry, we need to establish new visions and strategies,” and added, “Amid rapidly changing environments, the domestic pharmaceutical and bio healthcare industry aims to proactively respond to changes and lead the global market through the alliance.”‘,
,
, ‘Participants shared a deep understanding of the importance of building a sustainable industrial ecosystem that combines governance-based integrated industry policies, legislative issues, and the voices of the industry on the field.’,
,
, ‘The alliance plans to diagnose current issues in the pharmaceutical and bio healthcare industry, and to seek common solutions, it will hold a large-scale forum in the second half of the year, in collaboration with the 22nd National Assembly Health and Welfare Committee.’,
,
, ‘The alliance also plans to hold small seminars to discuss various measures to promote industrial growth in areas such as research and development, big data, IPO, fundraising, tax support, and legislative issues supporting the development of advanced medical products.’,
,
,